Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 29Recruiting 5Unknown 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Classical hematology 1

Conditions

Sarcoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Fanconi Anemia, Complementation Group D1 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Trabectedin × Clear all
NCT05131386 2023-03-27

SYNERGIAS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown
85 enrolled
Sarcoma

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02359474 2023-02-28

HyperTET

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
120 enrolled
Sarcoma

Sarcoma

NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡